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Hepatitis C virus (HCV) causes liver diseases, such as hepatitis, liver cirrhosis, steatosis, and
hepatocellular carcinoma. To understand the life cycle and pathogenesis of HCV, the one-step growth
of HCV in a cell culture system was analyzed using a highly infectious variant of the JFH1 clone. The
observed proﬁles of HCV RNA replication indicated that the synthesis of negative-strand RNAs occurred
at 6 h (h) after infection, followed by the active synthesis of positive-strand RNAs. Our measurements of
infectious virus production showed that the latent period of HCV was about 12 h. The speciﬁc
infectivity of HCV particles (focus-forming unit per viral RNA molecule) secreted to the extracellular
milieu early in infection was about 30-fold higher than that secreted later during infection. The buoyant
densities of the infectious virion particles differed with the duration of infection, indicating changes in
the compositions of the virion particles.
& 2012 Elsevier Inc. All rights reserved.Introduction
Over 170 million people worldwide are chronically infected
with hepatitis C virus (HCV), which is associated with hepatitis,
progressive hepatic ﬁbrosis, liver cirrhosis, and hepatocellular
carcinoma (Liang et al., 1993; Wasley and Alter, 2000).
HCV is a member of the Flaviviridae family of enveloped,
positive-strand RNA viruses (Bartenschlager and Lohmann,
2001). Its genome consists of a single-strand RNA molecule of
approximately 9.6 kb, which contains a large open reading frame
ﬂanked by 50 and 30 untranslated regions (UTRs). The viral RNA is
translated into a single large polyprotein of 3010-3040 amino
acids, which is co- and/or post-translationally processed by
cellular and viral proteases into a number of mature viral
proteins.
The replication steps of HCV have been investigated using HCV
replicons (Lohmann et al., 1999). Detailed stoichiometric analyses
of HCV RNA replication, carried out using crude replicase com-
plexes prepared from lysates of HCV subgenomic or full-length
replicons (Aizaki et al., 2004; Ali et al., 2002; El-Hage and Luo,
2003; Hardy et al., 2003; Lai et al., 2003; Quinkert et al., 2005),
have indicated that each cell harboring the full-length HCV
genome or subgenomic replicon contains approximately 100ll rights reserved.
ce, POSTECH Biotech Center,
g, South Korea
ng).negative-strand RNAs, 1000 positive-strand RNAs, and 100,000
copies of each viral protein (Quinkert et al., 2005). More recently,
the development of the infectious HCV clone, JFH1, and its
derivatives has enabled researchers to investigate the entire life
cycle of HCV (Lindenbach et al., 2005; Wakita et al., 2005; Zhong
et al., 2005). The HCV particles circulating in chronic HCV patients
or those produced in vitro showed heterogeneous densities
ranging from 1.06 to 1.20 g/ml (Andre et al., 2002; Cai et al.,
2005; Lindenbach et al., 2005; Nielsen et al., 2006; Wakita et al.,
2005; Zhong et al., 2005). The differences in the densities of virion
particles were attributed to the presence or absence of host
lipoproteins and antibodies bound to the circulating viral particles
(Gastaminza et al., 2010; Hijikata et al., 1993; Pumeechockchai
et al., 2002). The animal(chimpanzee)-derived HCV showed lower
buoyant density than the cell-derived HCV (Lindenbach et al., 2006).
In the case of HCV particles obtained from HCV patients, the density
proﬁles were found to differ by the stage of infection (Carabaich et al.,
2005; Pumeechockchai et al., 2002). Moreover, density gradient
analyses of viruses cultivated in vitro showed that virion particles
with densities of 1.10 to 1.14 g/ml had the highest speciﬁc
infectivity (deﬁned herein as focus-forming unit per viral RNA
molecule) (Gastaminza et al., 2006; Grove et al., 2008; Lindenbach
et al., 2005). An electron cryomicroscopic (cryoEM) analysis revealed
two major viral populations of 60 and 45 nm in diameter; the
60-nm particles, which were characterized by a membrane bilayer,
showed high speciﬁc infectivity (Gastaminza et al., 2010). Recent
studies have indicated that infectious virus assembly requires
members of the very-low-density-lipoprotein (VLDL) biosynthetic
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fer protein (Gastaminza et al., 2008; Huang et al., 2007; Nahmias
et al., 2008). ApoE, in association with an HCV particle, facilitates viral
infection via an interaction with the low-density-lipoprotein receptor
(LDLR) (Owen et al., 2009).
Using the in vitro cultivation systems, virus proliferation has
been investigated (Lindenbach et al., 2005; Wakita et al., 2005;
Zhong et al., 2005). However, the experiments were performed
with low multiplicity of infection (moi), which results in ensemble
proﬁles of virus proliferation including several generations of
viruses together. The relationship between HCV infectivity and
buoyant density of virus particles has been investigated with the
mixtures of HCV particles produced at various stages of infection.
In other words, characterization of viruses produced at speciﬁc
stage after infection has not been reported. Moreover, there was no
report showing the quantitative changes of positive- and negative-
strand HCV RNAs within the ﬁrst 24 h after infection. In order to
investigate the proﬁles of HCV proliferation during a single infec-
tion cycle, experiments with high titer of HCV (5 moi or higher)
sufﬁcient for infecting more than 99% of cells are needed.
In this study, we investigated HCV life cycle with high titer of
HCV (MOI¼5 or 6) using a cell culture–adapted infectious HCV
(JFH-m4) harboring adaptive mutations in the E2 and p7 proteinsFig. 1. Analysis of cell-associated and secreted HCV RNAs during the replication cycle. H
cultivated with complete DMEM. (A) Cell-associated RNAs were extracted from cells a
quantiﬁed using RT-qPCR. The number of HCV RNA molecules per cell was calculated b
number at each time point. The mean values and standard deviations obtained from th
summarizing the quantities of positive- and negative-strand HCV RNAs per cell shown
amount of negative-strand RNAs at 3 h pi was under the detection limit. (C) The med
30 min at 37 1C, as previously described (Gastaminza et al., 2006).The remaining RNAs w
RNAs were puriﬁed, and the positive-strand RNAs were quantiﬁed. The amounts of secre
(white columns) to clearly indicate the total amounts of RNA.(Kim et al., 2011). When cells are inoculated with 5 MOI,
theoretically 99.3% of cells are infected with at least one infec-
tious virion particle. With this approach, we obtained one-step
growth curve of HCV since superinfection of HCV does not occur
to the HCV-infected cells (Tscherne et al., 2007). With this
synchronized infection system, we analyzed the proﬁles of HCV
RNA replication, infectious virus production, and the properties of
HCV particles produced during early and late stage after infection.Results
The ratio of positive- to negative-strand RNA changes as HCV
infection proceeds
To obtain a high titer of HCV, we collected a large amount of
virus and concentrated virus as described in the Materials and
methods section. Core proteins were observed from approxi-
mately 95% of cells by immune-staining at 18 h after inoculation
of HCV (MOI¼5) to Huh7.5.1 cells (data not shown) indicating
that viruses were actively proliferating in most of cells. To
determine the proﬁles of HCV RNA replication during HCV
infection, Huh7.5.1 cells (4104 cells/well in a 24-well plate)uh7.5.1 cells were incubated with HCVcc at a MOI of 6 FFU/cell for 3 h, and then
t the indicated times, and then the positive- and negative-strand HCV RNAs were
y dividing the number of HCV positive- and negative-strand RNAs by the total cell
ree independent experiments are depicted as dots and bars, respectively. (B) Table
in panel (A). The ratios of positive- to negative-strand RNAs are also depicted. The
ia of HCV-infected cells were harvested and treated with RNase A (40 mg/ml) for
ere puriﬁed and quantiﬁed by RT-qPCR. (D) The cell-associated and secreted HCV
ted RNAs (black columns) are shown on top of the amounts of cell associated RNAs
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units (FFU) in 300 ml containing 5108 copies of HCV RNA,
MOI¼5 FFU/cell) at 37 1C for 3 h, and viral RNAs were isolated
from cells and culture supernatants at the times indicated in
Fig. 1A and then the amount of HCV RNAs were quantiﬁed by
qRT-PCR. We conﬁrmed that self and/or false priming events did
not occur at the qRT-PCR assays used in the quantiﬁcation of
positive- and negative-sense viral RNAs (Fig. S1). Similar to the
ﬁndings of previous reports (Lindenbach et al., 2005; Wakita
et al., 2005; Zhong et al., 2005) the infectious virus dose per viral
RNA molecule (speciﬁc infectivity) was approximately 1 out of
1000 RNA molecules. Immediately after the adsorption period of
3 h, we detected 5.5105 copies of positive-strand HCV RNA in
the total infected cells, indicating that 1 out of every 1000 copies
of positive-strand HCV RNA had entered or associated with cells.
The number of positive-strand HCV RNAs subsequently deceased,
reaching a minimum average level of 1 positive-strand RNA per
cell at 6 h pi (Fig. 1A and B). In contrast, negative-strand HCV
RNAs, which serve as the template for the synthesis of new
positive-strand HCV RNAs, were ﬁrst detected at 6 h pi, indicating
that the negative-strand HCV RNA was ﬁrst synthesized at an
early stage of RNA replication. This is similar to the case of theFig. 2. The kinetics of infectious virus production. (A) Huh7.5.1 cells inoculated with HC
media and the HCV-infected cells were collected and subjected to measurement of th
(secreted viral titer) and in the cell lysates (cell-associated viral titer) were determined
three independent experiments are depicted as dots and bars, respectively. (B) The re
various stages after infection are depicted as columns. (C) The levels of viral and host p
antibodies. (D) The effect of HCV infection on cell growth. At the indicated times after
were trypsinized at 37 1C for 3 min, and cell numbers were counted using a hemocytom
experiments are depicted as dots and bars, respectively. (E) The viability of HCV-infecte
relative cytotoxicities of samples at various times after infection were determined by s
values and standard deviations obtained from three independent experiments are depyellow fever virus (Lindenbach and Rice, 1997). The amount of
positive-strand RNA remained almost the same level between
6 h pi and 9 h pi, whereas the amount of negative-strand RNA
increased 14-fold during this period (Fig. 1A and B). Surprisingly,
the ratio of positive- to negative-strand RNA was almost 1:1 at
9 h pi. The amounts of both positive- and negative-strand RNAs
increased equally from 9 to 12 h pi, indicating that both positive-
and negative-strand RNAs were ampliﬁed during this stage of
infection. Synthesis became biased toward positive-strand RNAs
after 12 h pi, with the ratio of positive- to negative-strand RNA
eventually reaching about 100:1 at 120 h pi (Fig. 1B). The largest
amounts of viral RNA were produced at 48 and 72 h pi, with viral
RNA production decreasing gradually thereafter (Fig. 1A and B).
To measure the secretion of HCV RNAs, the amounts of
positive-strand HCV RNAs were measured in the cell culture
media (Fig. 1C). Unencapsidated HCV RNAs, which could have
originated from killed and/or ruptured cells, were removed from
the media using RNase A (40 mg/ml), as described in the Materials
and methods section. No signiﬁcant difference in the amounts of
HCV RNAs with and without RNase A treatment was observed
(data not shown). Secreted HCV RNAs were ﬁrst detected at
12 h pi, when an average of 1 RNA molecule was secreted perVcc at a MOI of 6 FFU/cell were cultivated for the indicated times, and the culture
eir infectious HCV titers. The infectious virus titers at various stages in the media
by infecting naı¨ve cells. The mean values and standard deviations obtained from
lative amounts of cell-associated (black) and secreted (gray) infectious viruses at
roteins were determined by Western blotting using core-, E2-, and GAPDH-speciﬁc
infection, HCV-infected cells (gray lines) and uninfected control cells (black lines)
eter. The mean values and standard deviations obtained from three independent
d and uninfected Huh7.5.1 cells was determined using a ToxiLight bioassay kit. The
etting the luciferase activity in uninfected cells at the starting point¼1. The mean
icted as columns and bars, respectively.
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average. After this stage, the amount of HCV RNAs secreted from
cells gradually increased until 120 h pi. To examine the ratios of
cell-associated to secreted HCV RNAs, we analyzed the quantities
of positive-strand RNAs at the indicated times (Fig. 1C and D).
Less than 10% of the HCV RNAs were secreted into the culture
media at each time measured. Because the amount of secreted
RNAs continually increased while the level of cell-associated HCV
RNAs did not, the proportion of secreted RNAs was highest at
120 h pi (Fig. 1C and D). We observed the similar patterns of
proﬁles of cell-associated and secreted HCV RNAs with qRT-PCR
using tagged primers to improve strand-speciﬁc detection of
RNAs (Fig. S2) (Bessaud et al., 2008; Boncristiani et al., 2009;
Craggs et al., 2001; Lanford et al., 1995). These results indicate
that a small portion of HCV RNAs replicated in cells are secreted
into medium.
The majority of mature viruses are secreted into the medium
To determine the kinetics of infectious HCV production,
Huh7.5.1 cells (4104 cells/well in a 24-well plate) were infected
with a high titer HCV (MOI¼5, 2105 focus-forming units (FFU)
in 300 ml). After infection, the cell culture media and infected cell
lysates were collected at the indicated times (Fig. 2A), and viral
titers were measured by the determining the focus-forming units
(FFUs) of the samples. Right after the adsorption period of 3 h,
4102 infectious viruses were detected within the total cells.
Infectious viruses were not detected in cell lysates at 6–15 h pi.
At 18 h pi, newly produced viruses were ﬁrst detected in the cell
lysates (Fig. 2A). The titer of infectious viruses increased up toFig. 3. Changes in speciﬁc infectivity and apoE levels during HCV proliferation. Huh
complete DMEM. The culture medium was harvested every 12 h and replaced with fre
virus titer (gray line) in culture media collected at the indicated times were analyzed by
deviations obtained from three independent experiments are depicted as dots and ba
indicated times after infection. The log values of the infectious virus titer (FFU) divided
graph. The mean values and standard deviations obtained from three independent expe
(gray line) and control Huh7.5.1 cells (black line) were collected every 12 h, and the apo
level of apoE RNA was normalized by that of GAPDH mRNA, and then relative RNA le
standard deviations obtained from three independent experiments are depicted as dots
primers apoE-F(50-GTTGCTGGTCACATTCCTGG-30) and apoE-R(50’-CAGTTGTTCCTCCAGT
GAPDH-R(50-GAGGCAGGGATGATGTTC-30), respectively. (D) and (E) Huh7.5.1 cells wer
every 12 h. The apoE levels inside cells and culture media obtained at the indicated tim
of GAPDH and albumin proteins were monitored as controls of housekeeping and secr48 h pi, when 103 infectious viruses were detected within the
infected cells. Secretion of infectious viruses into the culture
medium was ﬁrst detected at 12 h pi, when HCV RNAs were also
detected in medium. This indicates that a period of about 12 h pi
is required for HCV to be produced. The infectious viral titers
peaked at 48 h pi, and then gradually decreased thereafter
(Fig. 2A). We next investigated the relative ratios of the cell-
associated to secreted infectious viral titers at various times after
HCV inoculation (Fig. 2A). The ratio of cell-associated to secreted
infectious viral particles reached 20% at 24 h pi, and then gradu-
ally decreased to 10% (Fig. 2B).
To examine the relationship between infectious virus produc-
tion and the level of viral proteins, Western blotting of HCV core
and E2 proteins was performed on cell lysates collected at the
indicated times (Fig. 2C). The core and E2 proteins were ﬁrst
detected at 18 h pi; they increased until 48 h pi, and plateaued
thereafter (Fig. 2C). This indicates that the viral protein levels
remain high in infected cells through the late stage of infection.
The effects of HCV infection on the host cells were monitored
by counting cell numbers in HCV-infected cultures versus unin-
fected controls. Huh7.5.1 cells (3104) were seeded and
cultivated in 24-well plates for 18 h before infection and then
infected with a high titer of HCV (MOI¼6). The cell growth
kinetics revealed that the cell numbers increased similarly in
both cultures until 108 h pi, but the growth rate was slightly
lower in HCV-infected cells compared to uninfected controls
(Fig. 2D). In HCV-infected cultures, however, the cell number
decreased between 108 and 120 h pi, and cytotoxicity, which was
monitored by adenylate kinase activity in the medium, was
detected at 120 pi (Fig. 2E) (Crouch et al., 1993; Kedmi and7.5.1 cells inoculated with HCVcc at a MOI of 6 FFU/cell were cultivated with
sh medium. (A) The number of HCV RNA molecules (black line) and the infectious
RT-qPCR and infectious dose titration, respectively. The mean values and standard
rs, respectively. (B) Speciﬁc infectivity of HCV in culture media collected at the
by the number of HCV RNA molecules at the indicated times are depicted in the
riments are depicted as dots and bars, respectively. (C) HCV-infected Huh7.5.1 cells
E mRNA levels inside cells at the indicated times were determined by RT-qPCR. The
vels are depicted by setting the RNA level at 12 h pi to 1. The mean values and
and bars, respectively. apoE and GAPDH mRNAs were quantiﬁed by using a apoE
TCCG-30) and a GAPDH primers GAPDH-F(50-CATTGACCTCAACTACATGG-30) and
e infected with HCV (D) or left uninfected (E), and cells and media were collected
e were determined by Western blotting using an apoE-speciﬁc antibody. The levels
etory proteins, respectively.
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show serious growth defects for at least 4.5 day (when they were
shedding infectious virion particles into the medium), but they
eventually succumbed to the virus.
The composition and speciﬁc infectivity of HCV co-varies during the
course of infection
Although the amount of HCV RNA secreted into the extra-
cellular milieu gradually increased during infection (Fig. 1C), the
infectious virion particles secreted into the medium increased
until 48 h pi and then gradually decreased thereafter (Fig. 2A).
This indicates that the speciﬁc infectivity of HCV changed during
the course of viral infection. However, it should be noted that the
amount of HCV RNA and the infectious units of virion particles
were measured using media containing the virion particles that
had accumulated up to the indicated time points (Figs. 1 and 2). In
order to investigate the properties of virions newly produced
within the 12 h prior to collection, culture media were harvested
every 12 h and replaced with fresh media. The amount of HCV
RNA and infectious virus units in the media were then measured
(Fig. 3). The amounts of HCV RNA secreted into the media
increased until 60 h pi, and then similar amounts of viral RNAs
were secreted until 120 h pi (Fig. 3A). In contrast, the infectious
virus titer in the medium increased until 60 h pi and then
decreased precipitously until 84 h pi, even though the amounts
of secreted viral RNAs remained the same during this period
(Fig. 3A). The infectious viral titer was unchanged from 84 h to
120 h pi. These ﬁndings indicate that the viral particles produced
during the early stage of infection (12–60 h pi) had 10–100 fold
higher speciﬁc infectivities than those produced during the late
stage of infection (72–120 h pi) (Fig. 3B). On average 1 infectious
unit per 50–150 viral RNA molecules was observed among viral
particles produced between 12 and 60 h pi, whereas 1 infectious
unit per 1000–5000 viral RNA molecules was observed after
72 h pi (Fig. 3B). This result indicates that virion particles pro-
duced at the early stage of infection were more infectious than
virus particles produced at the late stage of infection. In other
words, most of the HCV RNAs secreted during the late stage of
infection were not infectious.
Previous studies have suggested that apoE is required for the
formation of infectious HCV particles, and it is included in the
infectious HCV virions (Benga et al., 2010; Chang et al., 2007;
Jiang and Luo, 2009). In association with HCV virions, apoE
proteins facilitate viral entry through interactions with LDLR
and scavenger receptor class B member I (SR-BI) (Chang et al.,
2007; Hishiki et al., 2010; Jiang and Luo, 2009). Thus, we
investigated the role of apoE in HCV infection by monitoring the
amounts of apoE mRNA and protein in HCV-infected cells and the
amount of apoE protein secreted into HCV-infected culture media
(Fig. 3C and D). To observe newly secreted apoE proteins, HCV-
infected cells were subjected to medium changes every 12 h, and
the harvested media were assessed for apoE. The amount of apoE
mRNA in the HCV-infected cells decreased gradually and showed
a sharp drop between 48 and 60 h pi (Fig. 3C), and the amount of
apoE protein in the HCV-infected cells and culture media showed
similar patterns to that of apoE mRNA. However, drastic drop of
protein levels were observed between 60 and 72 h pi instead of
48–60 h pi (Fig. 3C). This indicates that the decrease of apoE
protein in the HCV-infected cells is largely attributed to the
decrease of apoE mRNA level. In contrast, there was no signiﬁcant
decrease of the apoE mRNA or protein level in control cells and
media through 120 h of cultivation (Fig. 3C and E). Interestingly,
the sharp drop in secreted apoE coincided with the decrease of
speciﬁc infectivity between 60 and 72 h pi (Fig. 3A, B and D).
In contrast, the secretion of HCV RNAs into the media increaseduntil 60 h pi and then remained the same through 120 h pi (black
line in Fig. 3A). In order to investigate whether the decreased level
of apoE protein into cell culture medium was responsible for a
decreased speciﬁc-infectivity, HCV neutralization experiments
were carried out using an apoE-speciﬁc antibody. The viruses
collected at different stages after infections were treated with an
apoE-speciﬁc antibody. The viruses collected at various stages
were neutralized by the apoE-speciﬁc antibody in dosage-
dependent manners (Fig. S3). Careful analysis of the data indi-
cated that the virion particles collected at early stage after
infection were more sensitive to the neutralizing antibody than
those collected at late stage after infection. The data suggest that
viruses produced at early stage after infection rely on the apoE-
dependent infection process more than those produced at late
stage after infection thus show higher infectivity. The data also
suggest that the infectious virion particles collected at the late
stage of infection also contain some apoE proteins, and that the
late stage of infections are, at least in part, facilitated by apoE.
These results indicate that the secretion of apoE is likely related
with the production of infectious virion particles but not with the
secretion of HCV RNA-containing particles and that the composi-
tion of virion particles may change during HCV infection cycle.
Characterization of HCV virion particles produced at different stage
after infection
Previous studies had revealed that the HCV RNA-containing
particles produced in cell culture display a broad range of buoyant
densities, suggesting the existence of HCV virions with different
components (Hijikata et al., 1993; Pumeechockchai et al., 2002).
The authors used mixtures of HCV particles produced at various
stages of infection. To investigate the properties of HCV particles
produced at speciﬁc stages of infection, we harvested the culture
media of HCV-infected cells every 12 h and analyzed the samples
by isopycnic sucrose density gradient. The amounts of HCV RNAs
in each fraction of sucrose gradient were quantiﬁed by RT-qPCR,
the titers of infectious HCV particles in each fraction were
determined by infection of naı¨ve Huh7.5.1 cells (Fig. 4). The
majority of viral RNAs were fractionated at buoyant densities
between 1.15 and 1.17 g/ml throughout the infection course
(black lines in Fig. 4A–C). Although the high buoyant density
fractions contained the highest amounts of viral RNA, only low levels
of infectious viruses were found in these fractions. This indicates that
most of the viral RNAs in the high density fractions are not infectious.
The fraction containing the highest titer of infectious HCV was the
lowest buoyant density fraction (o1.05 g/ml) from an early stage of
infection (36 h pi) (gray line in Fig. 4A). The infectivity of HCV
gradually decreased as time passed by (Fig. 4). Noticeably, the highest
infectivity fractions shifted toward the higher density fractions as
infection proceeded (1.05 g/ml at 36 h pi, 1.12 g/ml at 72 h pi and
1.14 g/ml at 108 h pi) (gray line in Fig. 4). A similar trend of viral
production was clearly observed when we analyzed the data in terms
of percentiles of infectious virus dose and the amount of viral RNA in
each fraction (Fig. S4). This indicates that highly infectious virion
particles of very low buoyant density (o1.05 g/ml) are produced
early in the infective process (36 h pi), whereas a large quantity of
poorly infectious virion particles with high buoyant densities are shed
from the infected cells thereafter.Discussion
We herein monitored HCV proliferation in a cell culture
system through synchronous infection of high titer viruses
and obtained a one-step growth curve for HCV for the ﬁrst
time. During HCV proliferation, the quantities of positive- and
Fig. 4. Characterization of HCV virion particles produced at different times after
infection. Huh7.5.1 cells inoculated with HCVcc at a MOI of 6 FFU/cell were
cultivated with complete DMEM. The culture media were harvested every 12 h
and replaced with fresh media. Culture media were harvested at 36 h (A), 72 h (B),
and 108 h (C) after HCV infection and concentrated to 1 ml with a Vivaspin (100-
kD cut-off). The concentrated culture media were subjected to 20–60% sucrose
density gradient centrifugation, and samples were collected from top to bottom.
The infectious virus titer (103 FFU/ml, gray line), HCV RNA (104/ml, black line) are
shown (A–C).
S. Ju Keum et al. / Virology 433 (2012) 462–470 467negative-strand viral RNAs were measured, and infectivity and
virion compositions were compared.
After the attachment of HCV onto cells, a sharp drop of cell-
associated level was observed at the very early stage of infection
(6 h pi). The production of negative-strand RNA was ﬁrst detected
at 6 h pi, and synthesis was biased toward negative-strand RNAs
until 9 h pi, when the molar ratio of positive- to negative-strand
RNA was around 1:1. This may indicate that almost all viral RNAs
at this stage (9 h pi) were the double-stranded RNAs called the
‘replicative intermediate’ (Chang et al., 2000). The ratio of viral
RNAs remained 1:1 until 12 h pi, even though the copy number of
viral RNAs almost doubled from 9 h pi to 12 h pi. After this stage,
biased synthesis of positive-strand RNAs occurred, until the ratio
of positive- to negative-strand RNA exceeded 100:1 at 120 h pi.
During this period (24 h to 120 h pi), it is likely that multiple
rounds of positive-strand RNA synthesis occurred from a singletemplate of negative-strand RNA, and new positive- strand RNA
syntheses may have commenced before completion of the prior
round, as seen in the syntheses of picornaviral RNAs (Belsham and
Normann, 2008).The HCV-infected cell has higher ratio of posi-
tive- to negative-strand RNA than subgenomic and full-length
replicons which have the ratio of less than 10. We can speculate
plausible reasons for this discrepancy. (1) The optimization of
replicons, which has only replication and translation steps of
virus life cycle, may result in less production of positive-sense
RNAs. That is, mass production of positive-sense RNA to be
encapsidated into virion particles is not needed for the main-
tenance of replicon in cells. (2) The infectious HCV clone JFH-1
was originated from a patient with fulminant hepatitis that is
caused by robust proliferation of HCV (Kato et al., 2007). Further
investigations will be needed to conﬁrm these speculations.
Infectious viruses were detected in the media at 12 h pi
(Fig. 2A) suggesting that the latent period of HCV is about 12 h.
To our knowledge, this is the ﬁrst report describing the latent
period of HCV. The cumulative titer of infectious HCV increased
until 60 h pi in both cell-associated and secreted viruses, and
decreased gradually thereafter (Fig. 2A).These kinetics of infec-
tious HCV production are similar to those reported previously by
Deborah et al. (Song et al., 2010). Here, we also monitored the
production of infectious virion particles over time, by harvesting
and changing the medium every 12 h after infection (Fig. 3A). The
secretion of infectious viruses increased until 60 h pi and then
precipitately decreased (gray line in Fig. 3A). In contrast, the
secreted HCV RNAs reached their highest level at 60 h pi and
remained high until 120 h pi (black line in Fig. 3A). The viral
RNAs, which are not encapsidated but resistant to RNase A, were
also included in calculating the amount of secreted HCV RNAs
since there is no suitable experimental method to discriminate
the encapsidated virion RNAs from unencapsidated but RNase-
resistant RNAs that are likely to exist in exosomes. Considering all
of RNase-resistant viral RNAs as variants of virion particles, the
speciﬁc infectivity of HCV was high during the early stage of
infection (12 to 60 h pi), and thereafter decreased 10- to 100-fold
during the later stages of infection (72 to 108 h pi) (Fig. 3B).
Previous studies showed that apoE is required for the forma-
tion of infectious HCV particles (Gastaminza et al., 2008; Huang
et al., 2007; Nahmias et al., 2008). However, the levels of apoE
inside and/or outside of HCV-infected cells during the infection
cycle have not been reported. We found that apoE protein levels
were much lower both inside and outside the HCV-infected cells
at the late stage of infection (Fig. 3D). In control cells, the amounts
of intracellular and secreted apoE remained unchanged through
120 h (Fig. 3E). The apoE mRNA levels were signiﬁcantly
decreased after 60 h pi (Fig. 3C), at which HCV-infected cells do
not show cytotoxicity (Fig. 2E). The levels of ApoE protein inside
and outside of the HCV-infected cells precipitately decreased in
following 12 h, that is, 72 h pi (Fig. 3D). This indicates that the
reduction of apoE protein level is largely attributed to the
reduction of apoE mRNA level. However, the molecular basis of
the modulation of apoE mRNA level in HCV-infected cells remains
to be elucidated. It is plausible that the virion particles produced
at the early stage of infection (12 to 60 h pi) are associated with
larger amounts of apoE proteins than those produced at the late
stage of infection, which results in the difference of speciﬁc
infectivity of HCV during the infection cycle. This result is
supported by a recent report showing that apoE proteins reside
on the surface of infectious virion particles (Merz et al., 2011).
However, the content of apoE may not be the sole reason of the
change of HCV infectivity. Other viral or cellular protein(s) may
also contribute to the change in speciﬁc infectivity of HCV during
the infection cycle. Further researches are needed to understand
the molecular details of the virus infectivity change.
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low density have higher infectivity. Moreover, it was found that
the low-density HCV particles were detected more often in acute
infection, while high-density HCV particles were detected more
often in chronic infection in patients (Pumeechockchai et al.,
2002; Watson et al., 1996). However, the basis for this phenom-
enon is not yet clearly understood. Here, we report that virus
particles produced during the early stages of infection are more
infectious and have a very low buoyant density (1.05 g/ml). As the
infection progresses, the peak of infectious virus particles shifts
toward the higher-density fractions (Fig. 4). The difference of
buoyant density among the HCV particles during the proliferation
cycle might be responsible for the heterogeneity of HCV particles
in HCV patients (Carrick et al., 1992; Kanto et al., 1994; Miyamoto
et al., 1992), and for the changes of infectivity and buoyant
densities during the pathogenic course of HCV (Pumeechockchai
et al., 2002; Watson et al., 1996). Thus, acutely infected patients
experience active new infections that produce low-density, highly
infectious HCV particles. In contrast, chronically infected patients
experience fewer new infections and HCV-infected cells at the
late stage of infection dominate the population, resulting in the
production of high-density, poorly infectious HCV particles.Conclusions
The one-step growth curve shown herein provides a founda-
tion for understanding the steps of HCV replication and the
production of various HCV particles during the proliferation cycle.
Additional investigations into the pathogenic relevance of the
changes in HCV infectivity and composition during the prolifera-
tion cycle will shed new light on the pathogenesis of HCV in
patients.Materials and methods
Cell line and cell culture
The human hepatoma cell line, Huh7.5.1 (Zhong et al., 2005),
was grown in Dulbecco’s modiﬁed Eagle’s medium (DMEM;
Gibco) supplemented with antibiotics (100 U/ml penicillin,
10 mg/ml streptomycin) and 10% fetal bovine serum (Hyclone)
at 37 1C in a humidiﬁed 5% CO2 environment.Viral production and concentration
In vitro transcription and RNA electroporation were performed
as previously described (Wakita et al., 2005). Approximately
3106 Huh7.5.1 cells were electroporated with in vitro-
transcribed RNAs derived from JFH1 containing the cell culture–
adapted virus in the E2 and p7 protein (Kim et al., 2011). Cell
culture media were collected 3–5 day after electroporation, and
naı¨ve Huh7.5.1 cells were infected with the generated viruses.
The cell culture media of infected cells were collected 3–5 day
post infection. The HCV-containing cell culture media were then
ﬁltered with a 0.45 mm and the ﬁltrates were concentrated with a
Vivaspin (Millipore; 100-kD cut-off). The concentrated HCV cul-
ture medium was loaded onto a 20% sucrose cushion, and HCV
particles were collected by ultracentrifugation at 4 1C for 4 h at
27,000 rpm (SW48 rotor; Beckman). The viral pellet was resus-
pended with complete medium (Chang et al., 2007).Measurement of infectious virus titer
The infectivity titer was determined on Huh7.5.1 cells by end-
point dilution followed by immunoﬂuorescence, as previously
described (Zhong et al., 2005). Brieﬂy, the virus stock was
subjected to 10-fold serial dilutions, and naı¨ve Huh7.5.1 cells
were infected with diluted virus for 3 h. After infection, the cells
were washed with PBS and overlain with complete DMEM
containing GUM tragacanth (Sigma) to prevent secondary infec-
tion (Kedmi and Katzenelson, 1978; Okuno et al., 1990). At 72 h
after infection, the cells were ﬁxed with 3% paraformaldehyde,
permeabilized with 0.1% Triton X-100 and incubated with a
monoclonal anti-core antibody (Thermo Scientiﬁc; 1:400 dilu-
tion). The core-expressing cells were visualized using Alexa Fluor
488-conjugated donkey anti-mouse IgG (Invitrogen, 1:200 dilution).
Infectivity titers were expressed as the number of infection focus-
forming units per ml (FFU/ml).Cytotoxicity assay
We used a ToxiLight bioassay kit (Lonza) to measure the
release of adenylate kinase (AK) following the loss of cell
membrane integrity. Culture media were harvested at the indi-
cated times, samples were incubated for 5 min with the AK
detection reagent, and the results were detected using a lumines-
cence reader (Crouch et al., 1993; Niles et al., 2009).Preparation of cell-associated and secreted RNAs, and quantiﬁcation
of RNAs by real-time RT-PCR
Cell culture supernatants harvested from infected Huh7.5.1
cells were treated with RNase A solution (ﬁnal concentration,
40 mg/ml) for 30 min at 37 1C, as previously described
(Gastaminza et al., 2006). Cellular RNAs were isolated using the
TRIzol reagent (Invitrogen), and HCV RNAs were isolated from
culture supernatants using the TRIzol LS reagent (Invitrogen).
From these samples, cDNAs were synthesized using Improm II
reverse transcriptase (Promega), and SYBR green qPCR was
performed using a Light Cycles 2 system (Roche). HCV transcript
levels were determined by comparison to standard curves derived
from serially diluted JFH1 plasmid. Quantitative real-time RT-PCR
(RT-qPCR) analysis of the HCV genome was performed using
primers speciﬁc for JFH1, as previously described (Kumthip
et al., 2012; Zhong et al., 2005). A pair of PCR primers (HCV-R
50-TCAGGCAGTACCACAAGGC-30, HCV-F 50-TCTGCGGAACCGGT-
GAGTA-30) was used to monitor positive- and negative- strand
HCV RNAs.Western blot analysis
HCV-infected cell lysates were prepared, and protein concen-
trations were determined using a protein assay reagent (Thermo
Scientiﬁc). HCV-infected cell lysates were resolved by 13.5%
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
(SDS-PAGE), and transferred onto a nitrocellulose membrane.
Western blotting was performed using core-, E2-, and GAPDH-
speciﬁc antibodies. The antibodies against core and E2 (AP 33)
were kindly provided by Ralf Bartenschlager (University of
Heidelberg) and Arvind Patel (University of Glasgow), respec-
tively. The antibody against GAPDH was purchased from SeroTec.
To quantify the amount of secreted apoE, 25 ml of cell culture
medium was resolved by 10% SDS-PAGE, and the level of apoE
was monitored by Western blotting using an apoE-speciﬁc anti-
body (Calbiochem).
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Cell culture supernatants were collected at the indicated times
and concentrated 10-fold with a Vivaspin (100-kD cut-off). The
concentrated supernatants were then loaded on the top of a
20–60% sucrose gradient prepared in TNE buffer (100 mM NaCl,
10 mM Tris–HCl, and 1 mM EDTA), which was centrifuged at
40,000 rpm and 4 1C for 16 h in a SW41 rotor (Beckman), as
previously described (Cai et al., 2005). A total of 12 fractions (1 ml
each) were collected from the top to the bottom of the sucrose
gradient. The sucrose in each fraction was diluted by adding 10 ml
of PBS, and the virion particles were precipitated by ultracentri-
fugation at 40,000 rpm and 4 1C for 16 h in a SW41 rotor (Beckman).
The resulting pellet was resuspended with 1 ml of serum-free
DMEM. The HCV RNAs in each fraction (250 ml) were extracted
with TRIzol LS reagent and quantiﬁed by RT-qPCR. The infectivity of
HCV virions in each fraction was determined by inoculating
Huh7.5.1 cells with 200 ml of resuspended sample from each
fraction.
Production of synthetic HCV RNA
The region corresponding to 50UTR-NS2 of JFH was cloned into
the NotI/EcoRI sites of plasmid pSK() vector. Positive- and
negative-strand HCV RNAs were synthesized by in vitro transcrip-
tion with T7 and T3 RNA polymerases, respectively. The DNA
templates in the transcription reactions were digested with
DNase I (Ambion), and the concentration of RNA was adjusted
to 11011 copies/ml.
Observation of effect of an apoE-speciﬁc antibody on HCV infectivity
Culture media harvested at the indicated times was incubated
with increasing concentrations (0, 0.4, 2, 10, and 50 mg/ml) of an
apoE antibody (Calbiochem) (Merz et al., 2011; Owen et al., 2009)
or a negative control goat IgG (Santa Cruz) antibody at room
temperature for 1 h. The antibody-treated culture media were
used in measuring infectious HCV titers.Acknowledgments
This research was supported by the World Class University
(WCU) Program (No. R31-10105), and the BRL (No. 2010-
0019706) through the National Research Foundation funded by
the Ministry of Education, Science and Technology. We are
grateful to Ralf Bartenschlager (University of Heidelberg) for the
core antibody, Arvind Patel (University of Glasgow) for the E2
antibody, Francis Chisari (Scripps Research Institute) for the Huh
7.5.1 cell line and Takaji Wakita (National Institute of Infectious
Disease, Tokyo, Japan).Appendix A. Supplementary information
Supplementary data associated with this article can be found
in the online version at http://dx.doi.org/10.1016/j.virol.2012.08.
046.References
Aizaki, H., Lee, K.J., Sung, V.M., Ishiko, H., Lai, M.M., 2004. Characterization of the
hepatitis C virus RNA replication complex associated with lipid rafts. Virology
324 (2), 450–461.
Ali, N., Tardif, K.D., Siddiqui, A., 2002. Cell-free replication of the hepatitis C virus
subgenomic replicon. J. Virol. 76 (23), 12001–12007.Andre, P., Komurian-Pradel, F., Deforges, S., Perret, M., Berland, J.L., Sodoyer, M.,
Pol, S., Brechot, C., Paranhos-Baccala, G., Lotteau, V., 2002. Characterization of
low- and very-low-density hepatitis C virus RNA-containing particles. J. Virol.
76 (14), 6919–6928.
Bartenschlager, R., Lohmann, V., 2001. Novel cell culture systems for the hepatitis
C virus. Antiviral Res. 52 (1), 1–17.
Belsham, G.J., Normann, P., 2008. Dynamics of picornavirus RNA replication within
infected cells. J. Gen. Virol. 89 (Pt 2), 485–493.
Benga, W.J., Krieger, S.E., Dimitrova, M., Zeisel, M.B., Parnot, M., Lupberger, J., Hildt, E.,
Luo, G., McLauchlan, J., Baumert, T.F., Schuster, C., 2010. Apolipoprotein E
interacts with hepatitis C virus nonstructural protein 5A and determines
assembly of infectious particles. Hepatology 51 (1), 43–53.
Bessaud, M., Autret, A., Jegouic, S., Balanant, J., Joffret, M.L., Delpeyroux, F., 2008.
Development of a Taqman RT-PCR assay for the detection and quantiﬁcation of
negatively stranded RNA of human enteroviruses: evidence for false-priming
and improvement by tagged RT-PCR. J. Virol. Methods 153 (2), 182–189.
Boncristiani, H.F., Rossi, R.D., Criado, M.F., Furtado, F.M., Arruda, E., 2009. Magnetic
puriﬁcation of biotinylated cDNA removes false priming and ensures strand-
speciﬁcity of RT-PCR for enteroviral RNAs. J. Virol. Methods 161 (1), 147–153.
Cai, Z., Zhang, C., Chang, K.S., Jiang, J., Ahn, B.C., Wakita, T., Liang, T.J., Luo, G., 2005.
Robust production of infectious hepatitis C virus (HCV) from stably HCV
cDNA-transfected human hepatoma cells. J. Virol. 79 (22), 13963–13973.
Carabaich, A., Ruvoletto, M., Bernardinello, E., Tono, N., Cavalletto, L., Chemello, L.,
Gatta, A., Pontisso, P., 2005. Proﬁles of HCV core protein and viremia in chronic
hepatitis C: possible protective role of core antigen in liver damage. J. Med.
Virol. 76 (1), 55–60.
Carrick, R.J., Schlauder, G.G., Peterson, D.A., Mushahwar, I.K., 1992. Examination of
the buoyant density of hepatitis C virus by the polymerase chain reaction.
J. Virol. Methods 39 (3), 279–289.
Chang, K.S., Jiang, J., Cai, Z., Luo, G., 2007. Human apolipoprotein e is required for
infectivity and production of hepatitis C virus in cell culture. J. Virol. 81 (24),
13783–13793.
Chang, M., Marquardt, A.P., Wood, B.L., Williams, O., Cotler, S.J., Taylor, S.L.,
Carithers Jr., R.L., Gretch, D.R., 2000. In situ distribution of hepatitis C virus
replicative-intermediate RNA in hepatic tissue and its correlation with liver
disease. J. Virol. 74 (2), 944–955.
Craggs, J.K., Ball, J.K., Thomson, B.J., Irving, W.L., Grabowska, A.M., 2001. Develop-
ment of a strand-speciﬁc RT-PCR based assay to detect the replicative form of
hepatitis C virus RNA. J. Virol. Methods 94 (1-2), 111–120.
Crouch, S.P., Kozlowski, R., Slater, K.J., Fletcher, J., 1993. The use of ATP biolumi-
nescence as a measure of cell proliferation and cytotoxicity. J. Immunol.
Methods 160 (1), 81–88.
El-Hage, N., Luo, G., 2003. Replication of hepatitis C virus RNA occurs in a
membrane-bound replication complex containing nonstructural viral proteins
and RNA. J. Gen. Virol. 84 (Pt 10), 2761–2769.
Gastaminza, P., Cheng, G., Wieland, S., Zhong, J., Liao, W., Chisari, F.V., 2008.
Cellular determinants of hepatitis C virus assembly, maturation, degradation,
and secretion. J. Virol. 82 (5), 2120–2129.
Gastaminza, P., Dryden, K., Boyd, B., Wood, M., Law, M., Yeager, M., Chisari, F.V.,
2010. Ultrastructural and biophysical characterization of hepatitis C virus
particles produced in cell culture. J. Virol..
Gastaminza, P., Kapadia, S.B., Chisari, F.V., 2006. Differential biophysical properties
of infectious intracellular and secreted hepatitis C virus particles. J. Virol. 80
(22), 11074–11081.
Grove, J., Nielsen, S., Zhong, J., Bassendine, M.F., Drummer, H.E., Balfe, P., McKeating,
J.A., 2008. Identiﬁcation of a residue in hepatitis C virus E2 glycoprotein that
determines scavenger receptor BI and CD81 receptor dependency and sensitiv-
ity to neutralizing antibodies. J. Virol. 82 (24), 12020–12029.
Hardy, R.W., Marcotrigiano, J., Blight, K.J., Majors, J.E., Rice, C.M., 2003. Hepatitis C
virus RNA synthesis in a cell-free system isolated from replicon-containing
hepatoma cells. J. Virol. 77 (3), 2029–2037.
Hijikata, M., Shimizu, Y.K., Kato, H., Iwamoto, A., Shih, J.W., Alter, H.J., Purcell, R.H.,
Yoshikura, H., 1993. Equilibrium centrifugation studies of hepatitis C virus:
evidence for circulating immune complexes. J. Virol. 67 (4), 1953–1958.
Hishiki, T., Shimizu, Y., Tobita, R., Sugiyama, K., Ogawa, K., Funami, K., Ohsaki, Y.,
Fujimoto, T., Takaku, H., Wakita, T., Baumert, T.F., Miyanari, Y., Shimotohno, K.,
2010. Infectivity of hepatitis C virus is inﬂuenced by association with
apolipoprotein E isoforms. J. Virol. 84 (22), 12048–12057.
Huang, H., Sun, F., Owen, D.M., Li, W., Chen, Y., Gale Jr., M., Ye, J., 2007. Hepatitis C
virus production by human hepatocytes dependent on assembly and secretion of
very low-density lipoproteins. Proc. Nat. Acad. Sci. U.S.A. 104 (14), 5848–5853.
Jiang, J., Luo, G., 2009. Apolipoprotein E but not B is required for the formation of
infectious hepatitis C virus particles. J. Virol. 83 (24), 12680–12691.
Kanto, T., Hayashi, N., Takehara, T., Hagiwara, H., Mita, E., Naito, M., Kasahara, A.,
Fusamoto, H., Kamada, T., 1994. Buoyant density of hepatitis C virus recovered
from infected hosts: two different features in sucrose equilibrium density-
gradient centrifugation related to degree of liver inﬂammation. Hepatology 19
(2), 296–302.
Kato, T., Matsumura, T., Heller, T., Saito, S., Sapp, R.K., Murthy, K., Wakita, T., Liang, T.J.,
2007. Production of infectious hepatitis C virus of various genotypes in cell
cultures. J. Virol. 81 (9), 4405–4411.
Kedmi, S., Katzenelson, E., 1978. A rapid quantitative ﬂuorescent antibody assay of
polioviruses using tragacanth gum. Arch. Virol. 56 (4), 337–340.
Kim, C.S., Keum, S.J., Jang, S.K., 2011. Generation of a cell culture–adapted hepatitis
C virus with longer half life at physiological temperature. PLoS One 6 (8),
e22808.
S. Ju Keum et al. / Virology 433 (2012) 462–470470Kumthip, K., Chusri, P., Jilg, N., Zhao, L., Fusco, D.N., Zhao, H., Goto, K., Cheng, D.,
Schaefer, E.A., Zhang, L., Pantip, C., Thongsawat, S., O’Brien, A., Peng, L.F.,
Maneekarn, N., Chung, R.T., Lin, W., 2012. Hepatitis C virus NS5A disrupts
STAT1 phosphorylation and suppresses type I Interferon signaling. J. Virol. 86
(16), 8581–8591.
Lai, V.C., Dempsey, S., Lau, J.Y., Hong, Z., Zhong, W., 2003. In vitro RNA replication
directed by replicase complexes isolated from the subgenomic replicon cells of
hepatitis C virus. J. Virol. 77 (3), 2295–2300.
Lanford, R.E., Chavez, D., Chisari, F.V., Sureau, C., 1995. Lack of detection of
negative-strand hepatitis C virus RNA in peripheral blood mononuclear cells
and other extrahepatic tissues by the highly strand-speciﬁc rTth reverse
transcriptase PCR. J. Virol. 69 (12), 8079–8083.
Liang, T.J., Jeffers, L.J., Reddy, K.R., De Medina, M., Parker, I.T., Cheinquer, H., Idrovo,
V., Rabassa, A., Schiff, E.R., 1993. Viral pathogenesis of hepatocellular carci-
noma in the United States. Hepatology 18 (6), 1326–1333.
Lindenbach, B.D., Evans, M.J., Syder, A.J., Wolk, B., Tellinghuisen, T.L., Liu, C.C.,
Maruyama, T., Hynes, R.O., Burton, D.R., McKeating, J.A., Rice, C.M., 2005.
Complete replication of hepatitis C virus in cell culture. Science 309 (5734),
623–626.
Lindenbach, B.D., Meuleman, P., Ploss, A., Vanwolleghem, T., Syder, A.J., McKeating, J.A.,
Lanford, R.E., Feinstone, S.M., Major, M.E., Leroux-Roels, G., Rice, C.M., 2006. Cell
culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro.
Proc. Nat. Acad. Sci. U.S.A. 103 (10), 3805–3809.
Lindenbach, B.D., Rice, C.M., 1997. Trans-complementation of yellow fever virus
NS1 reveals a role in early RNA replication. J. Virol. 71 (12), 9608–9617.
Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L., Bartenschlager, R., 1999.
Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line.
Science 285 (5424), 110–113.
Merz, A., Long, G., Hiet, M.S., Brugger, B., Chlanda, P., Andre, P., Wieland, F.,
Krijnse-Locker, J., Bartenschlager, R., 2011. Biochemical and morphological
properties of hepatitis C virus particles and determination of their lipidome. J.
Biol. Chem. 286 (4), 3018–3032.
Miyamoto, H., Okamoto, H., Sato, K., Tanaka, T., Mishiro, S., 1992. Extraordinarily
low density of hepatitis C virus estimated by sucrose density gradient
centrifugation and the polymerase chain reaction. J. Gen. Virol. 73 (Pt 3),
715–718.
Nahmias, Y., Goldwasser, J., Casali, M., van Poll, D., Wakita, T., Chung, R.T.,
Yarmush, M.L., 2008. Apolipoprotein B-dependent hepatitis C virus secretion
is inhibited by the grapefruit ﬂavonoid naringenin. Hepatology 47 (5),
1437–1445.Nielsen, S.U., Bassendine, M.F., Burt, A.D., Martin, C., Pumeechockchai, W., Toms,
G.L., 2006. Association between hepatitis C virus and very-low-density
lipoprotein (VLDL)/LDL analyzed in iodixanol density gradients. J. Virol. 80
(5), 2418–2428.
Niles, A.L., Moravec, R.A., Riss, T.L., 2009. In vitro viability and cytotoxicity testing
and same-well multi-parametric combinations for high throughput screening.
Curr. Chem. Genomics 3, 33–41.
Okuno, Y., Tanaka, K., Baba, K., Maeda, A., Kunita, N., Ueda, S., 1990. Rapid focus
reduction neutralization test of inﬂuenza A and B viruses in microtiter system.
J. Clin. Microbiol. 28 (6), 1308–1313.
Owen, D.M., Huang, H., Ye, J., Gale Jr., M., 2009. Apolipoprotein E on hepatitis C
virion facilitates infection through interaction with low-density lipoprotein
receptor. Virology 394 (1), 99–108.
Pumeechockchai, W., Bevitt, D., Agarwal, K., Petropoulou, T., Langer, B.C.,
Belohradsky, B., Bassendine, M.F., Toms, G.L., 2002. Hepatitis C virus particles
of different density in the blood of chronically infected immunocompetent and
immunodeﬁcient patients: Implications for virus clearance by antibody.
J. Med. Virol. 68 (3), 335–342.
Quinkert, D., Bartenschlager, R., Lohmann, V., 2005. Quantitative analysis of the
hepatitis C virus replication complex. J. Virol. 79 (21), 13594–13605.
Song, H., Li, J., Shi, S., Yan, L., Zhuang, H., Li, K., 2010. Thermal stability and
inactivation of hepatitis C virus grown in cell culture. Virol. J. 7, 40.
Tscherne, D.M., Evans, M.J., von Hahn, T., Jones, C.T., Stamataki, Z., McKeating, J.A.,
Lindenbach, B.D., Rice, C.M., 2007. Superinfection exclusion in cells infected
with hepatitis C virus. J. Virol. 81 (8), 3693–3703.
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K.,
Habermann, A., Krausslich, H.G., Mizokami, M., Bartenschlager, R., Liang, T.J.,
2005. Production of infectious hepatitis C virus in tissue culture from a cloned
viral genome. Nat. Med. 11 (7), 791–796.
Wasley, A., Alter, M.J., 2000. Epidemiology of hepatitis C: geographic differences
and temporal trends. Semin. Liver Dis. 20 (1), 1–16.
Watson, J.P., Bevitt, D.J., Spickett, G.P., Toms, G.L., Bassendine, M.F., 1996. Hepatitis
C virus density heterogeneity and viral titre in acute and chronic infection: a
comparison of immunodeﬁcient and immunocompetent patients. J. Hepatol.
25 (5), 599–607.
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D.R., Wieland, S.F.,
Uprichard, S.L., Wakita, T., Chisari, F.V., 2005. Robust hepatitis C virus infection
in vitro. Proc. Nat. Acad. Sci. U.S.A. 102 (26), 9294–9299.
